SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-152011
Filing Date
2017-05-01
Accepted
2017-05-01 16:40:10
Documents
11
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d384694d10ka.htm 10-K/A 1240486
2 EX-31.1 d384694dex311.htm EX-31.1 2598
3 EX-31.2 d384694dex312.htm EX-31.2 2604
4 GRAPHIC g384694g32m00.jpg GRAPHIC 100398
5 GRAPHIC g384694g48j47.jpg GRAPHIC 97198
6 GRAPHIC g384694g52a73.jpg GRAPHIC 96252
7 GRAPHIC g384694g72y55.jpg GRAPHIC 38030
8 GRAPHIC g384694g73n94.jpg GRAPHIC 66943
9 GRAPHIC g384694g88z38.jpg GRAPHIC 42437
10 GRAPHIC g384694g91n47.jpg GRAPHIC 72481
11 GRAPHIC g384694g94a56.jpg GRAPHIC 44307
  Complete submission text file 0001193125-17-152011.txt   2016643
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

IRS No.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-199861 | Film No.: 17801387
SIC: 2834 Pharmaceutical Preparations